GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Celltrion Inc (XKRX:068270) » Definitions » Cyclically Adjusted PB Ratio

Celltrion (XKRX:068270) Cyclically Adjusted PB Ratio : 7.80 (As of Jun. 05, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Celltrion Cyclically Adjusted PB Ratio?

As of today (2024-06-05), Celltrion's current share price is ₩188100.00. Celltrion's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ₩24,109.70. Celltrion's Cyclically Adjusted PB Ratio for today is 7.80.

The historical rank and industry rank for Celltrion's Cyclically Adjusted PB Ratio or its related term are showing as below:

XKRX:068270' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 6.66   Med: 13.74   Max: 38.33
Current: 7.31

During the past years, Celltrion's highest Cyclically Adjusted PB Ratio was 38.33. The lowest was 6.66. And the median was 13.74.

XKRX:068270's Cyclically Adjusted PB Ratio is ranked worse than
85.45% of 660 companies
in the Biotechnology industry
Industry Median: 1.745 vs XKRX:068270: 7.31

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Celltrion's adjusted book value per share data for the three months ended in Mar. 2024 was ₩81,536.856. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩24,109.70 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Celltrion Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Celltrion's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celltrion Cyclically Adjusted PB Ratio Chart

Celltrion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.21 24.95 11.86 8.73 9.03

Celltrion Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.84 7.76 6.77 9.03 7.93

Competitive Comparison of Celltrion's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Celltrion's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celltrion's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Celltrion's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Celltrion's Cyclically Adjusted PB Ratio falls into.



Celltrion Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Celltrion's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=188100.00/24109.7
=7.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Celltrion's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Celltrion's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=81536.856/118.8477*118.8477
=81,536.856

Current CPI (Mar. 2024) = 118.8477.

Celltrion Quarterly Data

Book Value per Share CPI Adj_Book
201406 8,670.153 99.353 10,371.380
201409 8,967.380 99.608 10,699.467
201412 9,556.600 99.098 11,461.179
201503 9,002.956 99.720 10,729.850
201506 10,717.382 100.050 12,730.997
201509 11,267.841 100.110 13,376.855
201512 11,558.254 100.220 13,706.565
201603 12,854.882 100.560 15,192.653
201606 13,319.391 100.790 15,705.715
201609 13,729.408 101.460 16,082.284
201612 14,135.315 101.560 16,541.450
201703 14,481.761 102.850 16,734.312
201706 15,260.974 102.610 17,675.974
201709 16,045.427 103.490 18,426.535
201712 16,166.714 102.990 18,655.955
201803 17,329.484 104.100 19,784.528
201806 17,945.555 104.130 20,481.974
201809 17,524.709 105.650 19,713.879
201812 17,564.645 104.350 20,004.961
201903 17,599.021 104.490 20,017.257
201906 18,220.479 104.880 20,647.044
201909 18,677.348 105.200 21,100.379
201912 20,053.251 105.120 22,672.020
202003 20,023.800 105.540 22,548.632
202006 21,095.612 104.870 23,907.361
202009 22,357.207 106.200 25,019.799
202012 23,306.795 105.765 26,189.652
202103 24,246.025 107.357 26,841.090
202106 25,238.444 107.579 27,882.228
202109 26,314.141 108.759 28,755.040
202112 27,568.903 109.676 29,874.255
202203 26,092.874 111.806 27,736.290
202206 27,228.280 114.083 28,365.524
202209 28,644.449 114.831 29,646.332
202212 30,040.423 115.200 30,991.571
202303 29,094.375 116.550 29,668.052
202306 29,902.321 117.140 30,338.271
202309 30,691.416 119.111 30,623.520
202312 81,949.941 118.848 81,949.941
202403 81,536.856 118.848 81,536.856

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Celltrion  (XKRX:068270) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Celltrion Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Celltrion's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Celltrion (XKRX:068270) Business Description

Industry
Traded in Other Exchanges
N/A
Address
13-6 SongDo-Dong, Yeonsu-gu, Incheon City, KOR, 406-840
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.

Celltrion (XKRX:068270) Headlines

No Headlines